Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
MMW Fortschritte Der Medizin
|
January 17, 2023
[Important developments in the therapy of AML]
Katharina Nickel
Oncology Research and Treatment
|
November 8, 2021
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Michael Heider, Katharina Nickel, Marion Högner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2019
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis
Marc Botteman, Katharina Nickel, Shelby Corman, et al.
BMC Infectious Diseases
|
February 27, 2021
Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Katharina Nickel, Nicholas J A Halfpenny, Sonya J Snedecor, et al.
BMC Infectious Diseases
|
April 13, 2021
Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Katharina Nickel, Nicholas J A Halfpenny, Sonya J Snedecor, et al.
Leukemia Research
|
March 6, 2020
Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland
Dries Deeren, Stefan Balabanov, Katharina Nickel, et al.
Cancer Medicine
|
July 2, 2020
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myeloma
Xiang Zhou, Maximilian J Steinhardt, Denise Grathwohl, et al.
Journal of Comparative Effectiveness Research
|
July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma
Svenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
Cancers
|
April 29, 2020
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou, Patricia Flüchter, Katharina Nickel, et al.
European Journal of Haematology
|
January 11, 2020
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma
Xiang Zhou, Maximilian Johannes Steinhardt, Johannes Düll, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
MMW Fortschritte Der Medizin
|
January 17, 2023
[Important developments in the therapy of AML]
Katharina Nickel
Oncology Research and Treatment
|
November 8, 2021
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Michael Heider, Katharina Nickel, Marion Högner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2019
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis
Marc Botteman, Katharina Nickel, Shelby Corman, et al.
BMC Infectious Diseases
|
February 27, 2021
Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Katharina Nickel, Nicholas J A Halfpenny, Sonya J Snedecor, et al.
BMC Infectious Diseases
|
April 13, 2021
Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Katharina Nickel, Nicholas J A Halfpenny, Sonya J Snedecor, et al.
Leukemia Research
|
March 6, 2020
Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland
Dries Deeren, Stefan Balabanov, Katharina Nickel, et al.
Cancer Medicine
|
July 2, 2020
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myeloma
Xiang Zhou, Maximilian J Steinhardt, Denise Grathwohl, et al.
Journal of Comparative Effectiveness Research
|
July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma
Svenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
Cancers
|
April 29, 2020
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou, Patricia Flüchter, Katharina Nickel, et al.
European Journal of Haematology
|
January 11, 2020
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma
Xiang Zhou, Maximilian Johannes Steinhardt, Johannes Düll, et al.
Page
of 2